Pharm Tech Agenda 2011.10.13: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
Simon.letellier (talk | contribs)
Simon.letellier (talk | contribs)
No edit summary
 
Line 3: Line 3:
====    Overview and (short) introduction about the topic (15min max.)====   
====    Overview and (short) introduction about the topic (15min max.)====   


::* Status in PHARM (Jürgen) - attached picture will be shown and explained
::::*Status in PHARM (Jürgen) - attached picture will be shown and explained


::* Status in PCD (Todd?)
::::*Status in PCD (Todd?)


====    Start of discussion ====
====    Start of discussion ====

Latest revision as of 17:48, 19 October 2011

Welcome and round of introduction (5min)

Overview and (short) introduction about the topic (15min max.)

  • Status in PHARM (Jürgen) - attached picture will be shown and explained
  • Status in PCD (Todd?)

Start of discussion

  • Overlaps and boundaries?
  • Questions of Todd:
  • The infusion-related systems that PCD profiles support include: BCMA (for point-of-care 5 rights verification), eMAR (for capturing when an administration is started) and a flow sheet / chart (time based chart that enables clinicians to view parameters from multiple sources - including devices - at a point in time)
  • Do you use similar systems in Europe?
  • Are there similar or additional systems that you use?
  • Examples of real-world systems that implement the Pharmacy domain actors?
  • Do you know of any differences between Pharmacy system integration / medication administration support in Europe vs. the U.S.?